The Ministry of Industry, Commerce and Tourism has selected the biotechnology company Canvax Biotech, among the 50 national projects of the Covid-19 Aid Plan.
The company presented its project for the regulatory validation and production of kits for the diagnosis of the SARS-CoV-2 coronavirus, which has a bankable budget of 139,437 euros and for which it will receive a total of 111,549 euros of subsidy (Project No.: COV-010000-2020-274).
“For Canvax this help means being able to improve our production capacities for two key reagents in the detection of Covid-19 – CVX-Mag ™ Viral RNA Extraction Kit (CE-IVD) and CVX ™ Viral RNA Extraction Minispin Kit (CE-IVD) -. Both have the European certificate of medical devices for in vitro diagnostics ”, explains Elier Paz, CEO of Canvax Biotech.